Clinical Trials Directory

Trials / Unknown

UnknownNCT02606539

Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms

Primary Surgery Plus Single Course Methotrexate Versus Primary Methotrexate for Treatment of Gestational Trophoblastic Neoplasms in Low Risk Cases Above 40y: a Randomized Controled Trial

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Maher elesawi kamel elesawi · Academic / Other
Sex
Female
Age
40 Years
Healthy volunteers
Not accepted

Summary

Gestational trophoblastic neoplasm affect women and is sensitive to chemotherapy especially methotrexate and the investigators try to find a role of surgery plus methotrexate instead of multiple doses and cycles of chemotherapy.

Detailed description

Gestational trophoblastic neoplasm affect women and is sensitive to chemotherapy espechialy methotrexate and the investigators try to find a role of surgery plus mehotrexate instead of multiple doses and cycles of chemotherapy that affect the patient quality of life and complication related to both line of management and time of decrease of B-hcg.

Conditions

Interventions

TypeNameDescription
PROCEDURETotal abdominal hysterectomy and methotrexateAfter written consent laparotomy will be done then pelvic examination for extra uterine spread, palpation of liver, omentum for any gross lesions and then hystrectomt bilateral salpigooophrectomy will be done) plus single course methotrexate(anti folate chemotheraputic agent, vial form given by intramuscular injection) 1mg/kg every other day alternating with calcium folinate 0.1 mg/kg for 4 doses each cycle then measuring B-HCG (the cycle may be repeated until normalization of B-HCG)
DRUGMethotrexate plus folinic acid alonemethotrxate 1mg/kg every other day alternating with calcium folinate 0.1 mg/kg for 4 doses each cycle then measuring B-HCG and cycle repeated until normalization of B-HCG

Timeline

Start date
2015-09-01
Primary completion
2017-06-01
Completion
2017-08-01
First posted
2015-11-17
Last updated
2017-03-22

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02606539. Inclusion in this directory is not an endorsement.

Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms (NCT02606539) · Clinical Trials Directory